Navigation Links
Isis Announces $1.2 Million Award to Its Ibis Subsidiary to Expand Influenza Detection Capabilities and Enable Large-Scale Influenza Transmission Studies
Date:9/26/2007

t of the funded research, Ibis will be analyzing a large number of samples generated from the influenza surveillance research.

"This grant will enable us to continue to advance our research in understanding the transmission of viral particles in order to prevent pandemic spread of virulent respiratory diseases, including influenza," said Frederick T. Koster, M.D., Associate Scientist, Infectious Diseases Program, Lovelace Respiratory Research Institute. "In order to screen large numbers of biological samples, we needed a technology partner that could provide high-resolution characterization of closely related viral strains, and could do so with appropriate sensitivity and high-throughput efficiency."

Respiratory diseases such as asthma, emphysema, influenza, and chronic bronchitis are on the increase worldwide. LRRI, one of the nation's largest independent research institutions and the only one focused solely on respiratory health, is committed to eradicating respiratory diseases through research aimed at understanding their causes and biological mechanisms, eliminating exposures to causal agents and developing more effective treatments.

Ibis' universal flu surveillance capabilities were described in a recent research study published in PLoS ONE in May 2007. In the study, Ibis' Dr. Sampath and colleagues report that they detected and correctly identified 92 mammalian and avian influenza isolates, including 29 avian H5N1 isolates. They also analyzed 656 human respiratory samples and showed correct, simultaneous identification of the viral species and subtypes with greater than 97 percent sensitivity and specificity.

ABOUT THE IBIS T5000 BIOSENSOR SYSTEM AND IBIS BIOSCIENCES, INC.

Ibis Biosciences, Inc., a wholly owned subsidiary of Isis Pharmaceuticals, has developed the Ibis T5000(TM) Biosensor System for rapid identification and characterization of infectious agents. The Ibis T5000 is capable of identifying virtually all bacteria, viru
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Sygnis Pharma AG announces date for presentation of clinical results
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... MIRAMAR BEACH, Fla. , June 30, 2015  July ... our country,s declaration of independence, and the spirit and people ... For Heroes Foundation has partnered with USA ... cards, to help increase funding for programs that empower independence ... across the country, and help more people afford their prescriptions. ...
(Date:6/30/2015)... 2015  Marken, the leading clinical trial logistics organization ... has been granted permission by the government to deliver ... product in Korea.  This precedent-setting shipment has allowed several ... continue receiving their clinical trial drugs during the outbreak ... emergency was caused by recent partial closures of medical ...
(Date:6/30/2015)... -- Legal-Bay LLC, the Lawsuit Settlement Funding Company, announced ... litigation (MDL) over the Zimmer NexGen Knee implant lawsuits ... 2015. There are currently more than a thousand cases ... federal judge in Illinois . The ... in October of this year. Zimmer Inc. previously issued ...
Breaking Medicine Technology:Hope For Heroes and USA Medical Card Make a Difference for Our Nation's Heroes 2Marken Delivers Direct To Patients During MERS Outbreak 2Marken Delivers Direct To Patients During MERS Outbreak 3Legal-Bay Lawsuit Settlement Funding Reports Zimmer NexGen Knee Bellwether Trial to Begin October 13th, 2015 2Legal-Bay Lawsuit Settlement Funding Reports Zimmer NexGen Knee Bellwether Trial to Begin October 13th, 2015 3
... ROCKVILLE, Md., Feb. 18, 2011 Novavax, Inc. ... today presented the final safety and immunogenicity results from ... clinical trial in Mexico at the invitation-only 7th World ... Vaccines in Clinical Trials. The meeting was held at ...
... Feb. 18, 2011 FUJIFILM Medical Systems ... footprint mobile application enabling remote access to ... as well as Macintosh- or Windows-based PCs.  Differentiated from ... quality, interactive three dimensional medical images in any platform ...
Cached Medicine Technology:NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting 2NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting 3NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting 4NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting 5Fujifilm's Synapse® Mobility Extends Imaging Reach 2
(Date:6/30/2015)... ... July 01, 2015 , ... Carey Danis & ... being managed in a West Virginia federal court. The court document outlined the ... date for the 26 cases.¹ , Carey Danis & Lowe is a personal injury ...
(Date:6/30/2015)... ... ... Down is a reputable source of authentic Kid Rock tickets at the DTE Energy ... road again this summer in what is one of the most affordable summer tours in ... this year at the XFINITY Theatre in Hartford, CT on June 24th and the blockbuster ...
(Date:6/30/2015)... ... June 30, 2015 , ... The board certified ... ‘responsive design’ website to inform potential sinus surgery patients about ear, nose, and ... includes information about a wide variety of ENT issues including hearing loss, ear ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... pleased to announce it’s own Debby Mann, CPC, RCC, ROCC, Coding Documentation and ... Summit with the Special Recognition Award for her contribution to the RBMA Coding ...
(Date:6/30/2015)... , ... June 30, 2015 , ... ... in a new video, “Grand Terrace Health Care Center.” Each year, Medicare ranks ... help patients find the best facility for their needs. Grand Terrace prides itself ...
Breaking Medicine News(10 mins):Health News:Carey Danis & Lowe Comments on New Pretrial Order in Vaginal Mesh Lawsuit 2Health News:Carey Danis & Lowe Comments on New Pretrial Order in Vaginal Mesh Lawsuit 3Health News:Cheap Kid Rock Tickets at the DTE Energy Music Theatre in Clarkston: Ticket Down Has Slashed Prices On All Kid Rock Tickets at DTE in the Detroit Metro Area 2Health News:Clear Lake Medical Center ENT Launches ‘Responsive Design’ Website 2Health News:Clear Lake Medical Center ENT Launches ‘Responsive Design’ Website 3Health News:ADVOCATE’s Debby Mann Honored With Special Recognition Award 2Health News:Grand Terrace Health Care Center Announces Five-Star Rating in YouTube Video 2
... - Innovation Explorers Unites 300 Researchers ... Elsevier, the leading publisher of scientific, technical and ... of Innovation,Explorers, an online community of 300 researchers ... chats to one-on-one interviews,the members will help Elsevier ...
... medical device packagers to new ISO Class 8 clean room , ... ... room production capabilities, Tray-Pak wanted a unique way to get the message ... and other plastic packaging decided to take a shot at producing their ...
... as Liaison Counsel and taking active roles in the Federal Court ... nephrogenic systemic fibrosis . The Federal Judge presiding over these ... , ... Cleveland, Ohio (PRWEB) March 25, 2009 -- Since ...
... as risk factors for breast cancer. Now a study published ... has found that even taking these factors into consideration, black ... ,triple negative tumour, compared to women of other racial backgrounds. ... of breast cancer in the world, the overall incidence of ...
... in JAMA: Penn Author Urges Changes that Hold ... March 24 Even when their products are ... information technology (HIT) currently enjoy wide contractual and ... Ross Koppel, Ph.D., of the University of ...
... Heart experts stress the importance of genetic testing and ... rare genetic heart disorder called Danon disease progresses rapidly ... a new study. , The recently recognized disease is ... to genetic mutations in the lysosome-associated membrane protein gene ...
Cached Medicine News:Health News:Elsevier Partners With Communispace to Launch Global Online Community 2Health News:Elsevier Partners With Communispace to Launch Global Online Community 3Health News:Tray-Pak Direct Mailer Garners 21% Response, Design Award 2Health News:Cleveland Trials Set In Nephrogenic Systemic Fibrosis (NSF) Gadolinium MRI Side Effects Cases 2Health News:Cleveland Trials Set In Nephrogenic Systemic Fibrosis (NSF) Gadolinium MRI Side Effects Cases 3Health News:Cleveland Trials Set In Nephrogenic Systemic Fibrosis (NSF) Gadolinium MRI Side Effects Cases 4Health News:Why Are Healthcare Information Manufacturers Free of All Liability When Their Products Can Result in Medical Errors? 2Health News:Why Are Healthcare Information Manufacturers Free of All Liability When Their Products Can Result in Medical Errors? 3Health News:Danon Disease Can Be Quickly Fatal, Study Finds 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: